Komori
Results219AHeartseed Inc.Pharmaceuticals

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Non-consolidated)

For the cumulative third quarter, revenue was ¥467 million and the operating loss was ¥1,131 million, resulting in a shift from the operating profit recorded in the same period of the previous year to an operating loss. However, year-on-year comparisons have not been disclosed because the previous fiscal year covered 14 months and the comparison periods differ, and the full-year forecast has not been revised.

Worth reading
44Recurring
Scored from 5 of 6 sections
Direction
Deterioration
Direction inferred from the company’s description.
Scale
-1131.528
¥ millions (operating loss)
Wording
Conditional
How definitive the wording is.

Results for this period

Third quarter1 January 2026 to 30 September 2026Non-consolidated (individual)Japanese GAAP
Net Sales467Millions of yenProgress 100.0%
Operating profit-1,131Millions of yen
Ordinary income-1,058Millions of yen
Net income attributable to owners of the parent-1,062Millions of yen

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share-¥46.44
Financial position at period-end
Total assets7,017Millions of yen
of which net assets 6,177 Millions of yenEquity ratio 88.0%vs. prior year-end -5.7pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Outlook and shareholder returns
Full-year earnings forecast
Net Sales467 Millions of yen
Operating profit-2,207 Millions of yen
Ordinary income-2,155 Millions of yen
Net income-2,158 Millions of yen
Annual Dividend Forecast0 Yen → 0 Yen
Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noneそれ以外の変更 None見積りの変更 None修正再表示 None
Depreciation and amortization35,953 Thousands of yen
Availability of Supplementary Financial Results MaterialsAvailable
Availability of Financial Results BriefingWhether applicable Available / Subject person Institutional investors and securities analysts
Issued Shares at Period-End22,929,400 shares
Treasury Shares at Period-End— shares
Results for this period
ItemDetails
Fiscal Period ClassificationThird quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedNon-consolidated (individual)
Period Covered1 January 2026 to 30 September 2026
Net Sales467 Millions of yen
Operating profit-1,131 Millions of yen
Ordinary income-1,058 Millions of yen
Profit attributable to owners of the parent-1,062 Millions of yen
Net income per share-¥46.44
Equity ratioEnd of the current fiscal period 88.0% / End of previous period 93.7%
Total assets7,017 Millions of yen
Net assets6,177 Millions of yen
Full-year earnings forecastNet Sales 467 Millions of yen / Operating profit -2,207 Millions of yen / Ordinary income -2,155 Millions of yen / Net income -2,158 Millions of yen
Annual Dividend Forecast0 Yen → 0 Yen
Depreciation and amortization35,953 Thousands of yen
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None
Availability of Supplementary Financial Results MaterialsAvailable
Availability of Financial Results BriefingWhether applicable Available / Subject person Institutional investors and securities analysts
Issued Shares at Period-End22,929,400 shares
Treasury Shares at Period-End— shares
Items this document does not state (17)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)Changes in the scope of consolidationMaterial subsequent eventsFactors Behind Changes in Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company explained that it has not provided year-on-year comparisons because the previous fiscal year covered 14 months and the comparison periods differ. The full-year earnings forecast remains unchanged from the forecast announced on 15 May 2026. No specific factors behind the deterioration in earnings have been provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Non-consolidated) | Heartseed Inc. (219A) timely disclosure | Komori